2026-05-11 · CARUSO JAMES V (Chief Executive Officer) · BUY
2025-12-16 · NEIS JOHN (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders32
Shares held3,607,671
Value$9.93M
Percent of shares outstanding38.17%
As of quarter end2026-06-30
RECENT NEWS
Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia